PFBT
DAWN

Parkside Financial Bank & Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61K Hold
75
– – ﹤0.01% 2201
2025
Q4 		$699 Hold
75
– – ﹤0.01% 2472
2025
Q3 		$529 Buy
+75
New +$516 ﹤0.01% 2556
2025
Q2 		– Sell
-40
Closed -$318 – 2799
2025
Q1 		$318 Buy
+40
New +$431 ﹤0.01% 2617

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Parkside Financial Bank & Trust's DAWN Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 75 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Parkside Financial Bank & Trust first reported a position in DAWN in Q1 2025 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Parkside Financial Bank & Trust held 75 shares of Day One Biopharmaceuticals worth $1.61K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2201 holding.
  • Parkside Financial Bank & Trust first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.